﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd"[]>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Science and Education Publishing</PublisherName>
      <JournalTitle>American Journal of Medical and Biological Research</JournalTitle>
      <Issn>2328-4099</Issn>
      <Volume>2</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>05</Month>
        <Day>27</Day>
      </PubDate>
    </Journal>
    <ArticleTitle>Association of Adipocytokines: Resistin and Retinol Binding Protein-4 with Severity of Preeclampsia and Insulin Resistance</ArticleTitle>
    <FirstPage>76</FirstPage>
    <LastPage>82</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Abeer A.</FirstName>
        <LastName>EL-Refai</LastName>
      </Author>
      <Author>
        <FirstName>Sameer H.</FirstName>
        <LastName>Fatani</LastName>
      </Author>
      <Author>
        <FirstName>Hala F. M.</FirstName>
        <LastName>Kamel</LastName>
        <Affiliation>Biochemistry Department, Faculty of medicine, Umm Al-Qura University (UQU), Makkha, KSA</Affiliation>
      </Author>
    </AuthorList>
    <ArticleIdList>
      <ArticleId IdType="pii">AJMBR2014232</ArticleId>
      <ArticleId IdType="doi">10.12691/ajmbr-2-3-2</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>30</Day>
      </PubDate>
      <PubDate PubStatus="revised">
        <Year>2014</Year>
        <Month>04</Month>
        <Day>23</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2014</Year>
        <Month>05</Month>
        <Day>27</Day>
      </PubDate>
    </History>
    <Abstract>Dysregulation of maternal circulating adipocytokines has been implicated in several obstetrical syndromes including preeclampsia (PE). It has been suggested that adipocytokines provide a molecular link between metabolic derangements and inflammatory response in complicated pregnancies. We aimed in this study to evaluate the relationship between serum levels of Retinol binding protein-4 (RBP-4) and Resistin with clinical, anthropometric and metabolic parameters of PE. This study included 3 groups: group 1 included 50 pregnant females with PE, group 2 included 50 healthy pregnant females and group 3 included 50 healthy non-pregnant female as a control group. For all groups anthropometric and clinical measurements were performed. Serum RBP-4, resistin, insulin were measured by ELISA and Insulin resistance was calculated by Hemostasis model assessment index (HOMA-IR). Our results showed that serum RBP-4 and resistin concentrations were elevated in PE [39(33.25-40.87) ug/ml] &amp; [61(23.5-91.87) ng/ml] compared to normal pregnancy [18.5(8-27.87) ug/ml] &amp; [25.5(12.7-49.12) ng/ml). Moreover, RBP4 but not resistin levels were elevated in severe cases relative to mild cases of PE. Serum levels of RBP4 showed positive significant correlation with [SBP (r=0.38, p= 0.001) &amp; DBP (r=0.32, p=0.01)] which are markers of severity. Fasting insulin was positively correlated with RBP-4 (p=0.04). By multiple linear regression analysis, serum RBP-4 levels were significantly and positively correlated with SBP (P=0.01), while markers of adiposity were not independently associated with resistin. Conclusion: RBP-4 and resistin were up-regulated in PE, furthermore RBP-4 not resistin levels were independently associated with markers of severity of PE. However no clear relationship were observed between HOMA-IR with both RBP-4 and resistin and the role of Insulin resistance in PE was not clearly proved.</Abstract>
  </Article>
</ArticleSet>